CGC
Canopy Growth Corporation
NASDAQ · CAHealthcareDrug Manufacturers - Specialty & Generic
$0.93-0.64%
Price as of Jul 20, 2026
CGC profitability
Canopy Growth Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 24.9%
- EBITDA margin
- -65.7%
- EBIT margin
- -33.0%
- Net margin
- -91.6%
- Free cash flow margin
- -24.6%
Returns
- Return on equity
- -41.0%
- Return on assets
- -25.6%
- Return on invested capital
- -10.6%
- Asset turnover
- 0.24x
Cash efficiency
- Cash from operations
- -$50.1M
- Cash per share
- $0.62
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.